imipenem, anhydrous has been researched along with E coli Infections in 115 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (6.96) | 18.7374 |
1990's | 21 (18.26) | 18.2507 |
2000's | 32 (27.83) | 29.6817 |
2010's | 43 (37.39) | 24.3611 |
2020's | 11 (9.57) | 2.80 |
Authors | Studies |
---|---|
Barth, AL; Castanheira, M; Gales, AC; Nicoletti, AG; Pereira, AS; Pignatari, AC | 1 |
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Afkou, Z; Ikonomidis, A; Labrou, M; Maniatis, AN; Pournaras, S; Sofianou, D; Tsakris, A | 1 |
Bae, IK; Jeong, SH; Lee, SH; Lee, WG; Lee, YN | 1 |
Arakawa, Y; Suzuki, S; Wachino, J; Yamane, K | 1 |
Apisarnthanarak, A; Kiratisin, P; Laesripa, C; Saifon, P | 1 |
Cauda, R; D'Inzeo, T; De Pascale, G; Fadda, G; Fiori, B; Leone, F; Rossi, M; Sali, M; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M | 1 |
Jarlier, V; Mayer, C; Petrella, S; Renard, M; Sougakoff, W; Ziental-Gelus, N | 1 |
Cattoir, V; Nordmann, P; Poirel, L | 1 |
Carter, PE; Heffernan, HM; Pope, CE | 1 |
Carmeli, Y; Chmelnitsky, I; Goren, MG; Navon-Venezia, S | 1 |
Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ | 1 |
Cars, O; Löwdin, E; Melhus, A; Tängdén, T | 1 |
Blumstein, AC; Diethelm, S; Enderlin-Paput, M; Gauvin, JC; Gnerre, C; Herrmann, C; Jacob, L; Lange, R; Locher, HH; Masse, F; Mathieu, G; Mirre, A; Panchaud, P; Ritz, D; Rueedi, G; Schmitt, C; Seeland, S; Seiler, P; Surivet, JP | 1 |
Haider Naqvi, SZ; Malik, A; Muddassir, M; Mumtaz, K; Munir, S; Raza, A; Shoaib Ahmed, S; Waqas, K | 1 |
Ahmed, S; Ali, F; Andleeb, F; Gul, S; Rasheed, A; Sabir, MS; Sardar, S; Shakeela, Q; Ullah, A | 1 |
Al Atbee, MYN; Jalil, MB | 1 |
Akeda, Y; Hamada, S; Iida, T; Matsumoto, Y; Motooka, D; Sakamoto, N; Sugawara, Y | 1 |
Abulreesh, HH; Ahmad, I; Aldosari, MS; Alshehri, WA; Arafa, SH; Asiri, FH; Elbanna, K; Obaid, NA; Organji, SR | 1 |
Antonelli, A; Camarlinghi, G; Coppi, M; Giani, T; Mattei, R; Nardone, M; Parisio, EM; Riccobono, E; Rossolini, GM | 1 |
Fu, L; Li, H; Li, X; Liu, J; Luo, S; Wan, Z; Wang, Y; Wu, X; Xie, X; Zhao, Z | 1 |
Ebede, SO; Nwafia, IN; Ohanu, ME; Ozumba, UC | 1 |
Anacker, M; Castanheira, M; Johnson, JR; Johnston, BD; Porter, SB; Thuras, P; Vagnone, PS; VonBank, B; Witwer, M | 1 |
Canovas, J; Chau, F; Fantin, B; Le Monnier, A; Lefort, A; Petitjean, G | 1 |
Hirabayashi, A; Kajihara, T; Shibayama, K; Sugai, M; Yahara, K | 1 |
Clabots, C; Johnson, JR; Johnston, BD; Porter, SB; Thuras, P | 1 |
Debarbieux, L; Delattre, R; Dufour, N; Ricard, JD | 1 |
Ali, I; Shabbir, M | 1 |
Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
Abdelwahab, SI; Dafalla, OME; Homeida, HE; Taha, MME | 1 |
Bhattacharjee, A; Deshamukhya, C; Gajamer, VR; Paul, D; Pradhan, N; Singh, AK; Tiwari, HK | 1 |
Docobo-Pérez, F; Domínguez-Herrera, J; Egea, P; López-Cerero, L; López-Rojas, R; Pachón, J; Pascual, A; Rodríguez-Baño, J | 1 |
Chae, JY; Kim, JW; Moon, du G; Oh, MM; Park, MG; Yoon, CY | 1 |
Biçmen, M; Gülay, Z; Sarı, AN | 1 |
Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C | 1 |
Hidalgo, G; Hidalgo, M; Jugo, MB; Maccallini, GC; Villar, HE; Visser, M | 1 |
Camera, M; Coppo, E; Del Bono, V; Marchese, A; Orengo, G; Ventura, F; Viscoli, C | 1 |
Fernández, J; Fleites, A; Montero, I; Rodicio, MR | 1 |
Chau, F; Couffignal, C; Fantin, B; Lepeule, R; Massias, L; Mentre, F; Rossi, B; Ruppé, E; Soubirou, JF | 1 |
Cuesta-Bernal, J; El-Delik, J; Frank, D; Göttig, S; Klingler, FM; Koenigs, A; Müller, HF; Pogoryelov, D; Pos, KM; Proschak, E; Sjuts, H; Wichelhaus, TA | 1 |
Aissa, N; Bert, F; Labia, R; Lozniewski, A; Mayer, N; Nicolas-Chanoine, MH | 1 |
Chongtrakool, P; Diraphat, P; Malathum, K; Pornsinchai, P; Siripanichgon, K | 1 |
Aksaray, S; Avcıküçük, H; Başustaoğlu, A; Kaşkatepe, B; Süzük, S | 1 |
Hung, YP; Ko, WC; Lee, JC; Li, CW; Li, MC; Lin, HJ; Liu, HC; Wu, YH | 1 |
Ak, S; Ay Altıntop, Y; Balcı, PÖ; Budak, EE; Çalışkan, A; Çizmeci, Z; Çopur Çiçek, A; Fırat, M; Özgümüş, OB; Sancaktar, M; Sandallı, C; Sarı, F; Şay Coşkun, SU; Yağmur, G; Yıldız, N | 1 |
Ahmad, I; Akhtar, T; Ambreen, A; Gandapor, AJ; Khan, A; Khan, AM; Ullah, O | 1 |
Chen, ZL; Liu, SW; Wu, WK; Xu, J; Xu, XY; Yuan, JY; Zhang, N | 1 |
Boyanova, L; Kaneva, R; Markovska, R; Mitev, V; Mitov, I; Pencheva, D; Stankova, P; Stoeva, T | 1 |
Ajao, AO; Albrecht, JS; Furuno, JP; Harris, AD; Johnson, JK; Pineles, LL; Robinson, GL; Thom, KA; Zhao, L | 1 |
Fish, DE; Gluzman, A; Middleton, K | 1 |
Bautista, V; Campos, J; Delgado-Iribarren, A; García-Cobos, S; Martínez-Martínez, L; Oteo, J; Pérez-Vázquez, M; Rodríguez, MC; Saavedra, JM; Vega, D; Velasco, M | 1 |
Choe, KW; Jeon, JH; Kim, HB; Kim, NJ; Lee, HS; Oh, MD; Park, SW; Park, WB; Song, KH | 1 |
Ahmadi, S; Bazzaz, BS; Farshadzadeh, Z; Mohamadpoor, AH; Naderinasab, M; Yousefi, F | 1 |
Lim, KT; Puthucheary, S; Thong, KL; Yasin, R; Yeo, CC | 1 |
Lee, CH; Lin, WC; Liu, JW; Su, LH; Tang, YF | 1 |
Du, X; Jiang, X; Li, G; Wang, Y; Wei, Q; Zhao, Y | 1 |
Kochhar, R; Noor, MT; Radhakrishna, Y; Ray, P; Singh, K; Sinha, SK; Wig, JD | 1 |
Armero, C; Gobernado, M; González, F; López-Quílez, A; Perpiñán, H; Sahuquillo-Arce, JM; Selva, M; Vanaclocha, H | 1 |
Ersoy, Y; Görgeç, S; Kuzucu, C; Yetkin, F | 1 |
Hsueh, PR; Huang, WH; Ko, WC; Lee, NY; Tsui, KC | 1 |
Badal, RE; Bouchillon, SK; Cantón, R; Hackel, M; Hawser, SP; Hoban, DJ; Lascols, C | 1 |
Basu, S; Nandy, RK; Roy, S; Singh, AK; Viswanathan, R | 1 |
Chau, F; Fantin, B; Le, P; Lefort, A; Lepeule, R; Massias, L; Nucci, A; Ruppé, E | 1 |
Hsueh, PR; Huang, WH; Ko, WC; Lee, CC; Lee, NY; Tsui, KC | 1 |
Anderson, DJ; Bennett, KM; Dotson, TL; Sarraf-Yazdi, S; Sharpe, M; Vaslef, SN | 1 |
Bansal, N; Chander, J; Gupta, V; Singla, N | 1 |
Fallah, F; Goudarzi, M; Jahromi, MH; Karimi, A; Navidinia, M; Sajadi Nia, RS; Shiva, F | 1 |
Duttaroy, DD; González Patzán, LD; Kreidly, Z; Lipka, J; Sable, C; Stricklin, D; Vazquez, JA | 1 |
Harada, S; Ishii, Y; Kimura, S; Livermore, DM; Saga, T; Tateda, K; Woodford, N; Yamaguchi, K; Yoshizumi, A | 1 |
El-Sukhon, SN; Faiza Boukhatem, Z | 1 |
Ackermann, G; Beer, J; Blatz, R; Rodloff, AC; Schaumann, R | 1 |
Cirioni, O; D'Amato, G; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Sisti, V | 1 |
Héritier, C; Nordmann, P; Poirel, L; Spicq, C | 1 |
Cirioni, O; D'Amato, G; Ghiselli, R; Giacometti, A; Kamysz, W; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G; Silvestri, C; Łukasiak, J | 1 |
Benbachir, M; Benchekroun, S; Harif, M; Loukili, A; Mahmal, L; Quessar, A | 1 |
Abdalhamid, B; Fabian, D; Farajallah, A; Hanson, ND; Hong, T; Levine, J; Moland, ES; Sloan, C; Thomson, KS; Wang, J | 1 |
Arlet, G; Bidet, P; Bingen, E; Brahimi, N; Burghoffer, B; El-Ghoneimi, A; Gautier, V; Mariani-Kurkdjian, P | 1 |
Bergnach, C; Cirioni, O; Ghiselli, R; Giacometti, A; Licci, A; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G; Silvestri, C; Skerlavaj, B; Zanetti, M | 1 |
Choi, SJ; Lee, JH | 1 |
Antón-Aranda, E; Martí Cabané, J | 1 |
Lartigue, MF; Nordmann, P; Poirel, L; Poyart, C; Réglier-Poupet, H | 1 |
Carrero, HA; Erwin, DP; Ewell, AJ; Mody, RM; Moran, KA; Selby, EB; Summers, AM | 1 |
Melzer, M; Petersen, I | 1 |
McCracken, GH; Patamasucon, P | 1 |
Bucklin, SE; Lake, P; Lögdberg, L; Morrison, DC | 1 |
Akamo, Y; Manabe, T; Mizokami, M; Mizuno, I; Mohri, N; Shinagawa, N; Takeyama, H; Yuasa, H | 1 |
Bucklin, SE; Morrison, DC | 2 |
Isbister, WH; Sanea, O | 1 |
Bucklin, SE; Fujihara, Y; Leeson, MC; Morrison, DC | 1 |
Andremont, A; Carbon, C; Massias, L; Montravers, P | 1 |
Brook, I; Ledney, GD | 1 |
Casewell, M; Fagan, E; Gimson, A; Philpott-Howard, J; Rolando, N; Sahathevan, M; Westaby, D; Williams, R | 1 |
Dalhoff, A; Nitsche, D; Oesser, S; Sack, M; Schulze, C | 1 |
Ariga, K; Shinagawa, N; Suzuki, K; Yamakoshi, M; Yamamoto, T | 1 |
Hiramatsu, K; Tateda, E; Yokota, T; Yoshida, T | 1 |
Goto, S; Matsunaga, T; Nagashima, M; Ogawa, M; Shimohira, H; Yoshida, T | 1 |
Bradford, PA; Bush, K; Mariano, N; Projan, SJ; Rahal, JJ; Urban, C | 1 |
Hatakeyama, N; Horiguchi, A; Ikeuchi, K; Oyama, M | 1 |
Xiao, Z | 1 |
Abe, K; Oishi, Y; Ueda, M; Wada, T | 1 |
Cirioni, O; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Pacci, AM; Saba, V; Scalise, G | 1 |
Bonomo, RA; Hujer, AM; Kelkar, S; Odeh, R; Quinn, JP; Schreckenberger, PC | 1 |
Atkinson, AM; Teale, DM | 1 |
Kletchko, S; Nagappan, R | 1 |
Hopkins, JA; Lami, JL; Wilson, SE | 1 |
Guiot, HF; Mattie, H; van Furth, R; van Ogtrop, ML | 1 |
Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G | 1 |
Dworkin, RJ; Kennedy, SL; Sachdeva, M; Sande, MA; Tureen, JH | 1 |
Baron, S; Bégué, P; Challier, P; Fontaine, JL; Lasfargues, G; Quinet, B | 1 |
Brook, I | 1 |
Hashizume, T; Kemi, M; Komatsu, T; Ogashiwa, M; Okumoto, Y; Takase, Z | 1 |
Satoh, K; Watanabe, A | 1 |
Alpert, G; Bloh, AM; Campos, JM; Connor, E; Dagan, R; Plotkin, SA; Powell, KR | 1 |
Kim, KS | 1 |
1 review(s) available for imipenem, anhydrous and E coli Infections
Article | Year |
---|---|
[A case of psoas abscess associated in the elderly].
Topics: Aged; Aged, 80 and over; Cilastatin; Diabetes Complications; Drainage; Drug Therapy, Combination; Escherichia coli Infections; Humans; Imipenem; Male; Proteus Infections; Proteus mirabilis; Psoas Abscess; Sepsis | 1996 |
3 trial(s) available for imipenem, anhydrous and E coli Infections
Article | Year |
---|---|
Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cilastatin; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Protease Inhibitors; Pyelonephritis; Urinary Tract Infections | 2012 |
Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli Infections; Esophageal and Gastric Varices; Esophageal Diseases; Esophagoscopy; Female; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Sclerotherapy; Staphylococcal Infections; Staphylococcus aureus | 1993 |
Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems.
Topics: Adult; Aged; Bacterial Infections; Carbapenems; Cefmetazole; Cefoperazone; Cefotetan; Cefoxitin; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Remission Induction; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Thienamycins | 1991 |
111 other study(ies) available for imipenem, anhydrous and E coli Infections
Article | Year |
---|---|
First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Integrons; Latin America; Molecular Sequence Data; Plasmids | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-beta-lactamase VIM-12.
Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Humans; Male; Microbial Sensitivity Tests; Plasmids; Recombination, Genetic | 2007 |
Novel complex class 1 integron bearing an ISCR1 element in an Escherichia coli isolate carrying the blaCTX-M-14 gene.
Topics: Adult; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; DNA Transposable Elements; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Integrons; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Pneumonia, Bacterial; Sequence Analysis, DNA | 2007 |
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.
Topics: Anti-Bacterial Agents; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Hospitals; Humans; Japan; Microbial Sensitivity Tests; Plasmids; Prevalence | 2008 |
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
Topics: Adult; Bacterial Proteins; beta-Lactamases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Polymerase Chain Reaction; Sequence Analysis, DNA; Thailand | 2008 |
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Risk Factors; Treatment Failure | 2008 |
Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France.
Topics: Aged; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalytic Domain; Cephalosporin Resistance; Crystallography, X-Ray; DNA Primers; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; France; Genes, Bacterial; Humans; Imipenem; Kinetics; Male; Models, Molecular; Mutation | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
CMY-29 and CMY-30, two novel plasmid-mediated AmpC beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefoxitin; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; New Zealand; Plasmids | 2009 |
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
Topics: Academic Medical Centers; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Israel; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Time Factors | 2010 |
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2010 |
Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamases; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Sweden; Travel; White People; Young Adult | 2010 |
Optimization of LpxC Inhibitor Lead Compounds Focusing on Efficacy and Formulation for High Dose Intravenous Administration.
Topics: Administration, Intravenous; Amidohydrolases; Animals; Anti-Bacterial Agents; Enzyme Inhibitors; Escherichia coli Infections; Gram-Negative Bacteria; Hepatocytes; Hydroxamic Acids; Mice; Microbial Sensitivity Tests; Molecular Structure; Rats; Solubility | 2020 |
Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nitrofurantoin; Oxacillin; Pakistan; Pipemidic Acid; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2021 |
Comparative in vitro activity of selected antibacterial agents against Escherichia coli isolated from hospitalized patients suffering UTI.
Topics: Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Sulfamethoxazole; Tobramycin; Trimethoprim; Urinary Tract Infections | 2022 |
The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections.
Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefepime; Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Prevalence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2022 |
Role of Chromosome- and/or Plasmid-Located
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chromosomes; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Microbial Sensitivity Tests; Plasmids | 2022 |
Antimicrobial Resistance, Virulence Factor-Encoding Genes, and Biofilm-Forming Ability of Community-Associated Uropathogenic
Topics: Agar; Ampicillin; Animals; Anti-Bacterial Agents; Biofilms; Drug Resistance, Bacterial; Ertapenem; Escherichia coli Infections; Female; Imipenem; Meropenem; Norfloxacin; Saudi Arabia; Sheep; Urinary Tract Infections; Uropathogenic Escherichia coli; Virulence Factors | 2022 |
Variable performance of different commercial systems for testing carbapenem susceptibility of KPC carbapenemase-producing Escherichia coli.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Diagnostic Errors; Ertapenem; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Molecular Typing; Random Amplified Polymorphic DNA Technique | 2019 |
In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli.
Topics: Acinetobacter baumannii; Administration, Intravenous; Animals; Anti-Bacterial Agents; Biofilms; Colistin; Disease Models, Animal; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Monte Carlo Method; Sulbactam; Treatment Outcome; Urinary Tract Infections | 2020 |
Molecular detection and antibiotic resistance pattern of extended-spectrum beta-lactamase producing Escherichia coli in a Tertiary Hospital in Enugu, Nigeria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Genes, Bacterial; Humans; Imipenem; Male; Middle Aged; Nigeria; Risk Factors; Tertiary Care Centers; Young Adult | 2019 |
Activity of Imipenem-Relebactam against Carbapenem-Resistant Escherichia coli Isolates from the United States in Relation to Clonal Background, Resistance Genes, Coresistance, and Region.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Genotype; Geography; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; United States | 2020 |
Expression of CTX-M-15 limits the efficacy of ceftolozane/tazobactam against Escherichia coli in a high-inoculum murine peritonitis model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Cephalosporins; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Imipenem; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Peritonitis; Tazobactam | 2020 |
Geographical distribution of Enterobacterales with a carbapenemase IMP-6 phenotype and its association with antimicrobial use: An analysis using comprehensive national surveillance data on antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Japan; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Phenotype | 2020 |
Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Genotype; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Sisomicin; Young Adult | 2021 |
The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin Than by β-Lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Cell Survival; Coliphages; Endotoxins; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Phage Therapy; Spheroplasts | 2017 |
Antibiotics susceptibility patterns of uropathogenic E. coli with special reference to fluoroquinolones in different age and gender groups.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Imipenem; Infant; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Sulbactam; Tazobactam; Urinary Tract Infections; Young Adult | 2017 |
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2017 |
Multidrug resistance, prevalence and phylogenetic analysis of genes encoding class II and III integrons in clinically isolated Escherichia coli.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Base Sequence; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gentamicins; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Prevalence; Saudi Arabia; Sequence Alignment | 2018 |
Escherichia coli encoding bla
Topics: Adult; beta-Lactamases; Community-Acquired Infections; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Imipenem; India; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Plasmids; Urinary Tract Infections; Young Adult | 2018 |
Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactamases; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Female; Imipenem; Injections, Intramuscular; Injections, Intraperitoneal; Intraabdominal Infections; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Treatment Outcome | 2013 |
Positive culture for extended-spectrum β-lactamase during acute prostatitis after prostate biopsy is a risk factor for progression to chronic prostatitis.
Topics: Aged; Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Blood; Cefoxitin; Disease Progression; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Image-Guided Biopsy; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Prostate; Prostatitis; Quinolones; Urine | 2013 |
[Investigation of plasmid mediated AmpC beta-lactamases among Escherichia coli and Klebsiella pneumoniae isolated from blood cultures].
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Cefotaxime; Cefoxitin; Ceftazidime; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Plasmids | 2013 |
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index | 2014 |
[In vitro emergence of ertapenem resistance in Escherichia coli producing extended-spectrum β-lactamase].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Imipenem; Meropenem; Microbial Sensitivity Tests; Mutation; Thienamycins | 2014 |
Identification of a New Delhi metallo-β-lactamase-4 (NDM-4)-producing Escherichia coli in Italy.
Topics: Aged; Bacterial Proteins; beta-Lactamases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Imipenem; Italy; Male; Middle Aged; Multilocus Sequence Typing | 2014 |
Cluster of Escherichia coli isolates producing a plasmid-mediated OXA-48 β-lactamase in a Spanish hospital in 2012.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Gene Transfer, Horizontal; Genotype; Hospitals; Humans; Imipenem; Male; Middle Aged; Plasmids; Spain | 2014 |
Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Female; Imipenem; Mice, Inbred CBA; Microbial Sensitivity Tests; Penicillins; Treatment Outcome; Urinary Tract Infections | 2015 |
Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Crystallography, X-Ray; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Models, Molecular; Pseudomonas aeruginosa; Pseudomonas Infections; Sulfhydryl Compounds | 2015 |
A new mechanism to render clinical isolates of Escherichia coli non-susceptible to imipenem: substitutions in the PBP2 penicillin-binding domain.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Imipenem; Microbial Sensitivity Tests; Mutation, Missense; Penicillin-Binding Proteins; Recombination, Genetic; Reverse Genetics | 2016 |
EMERGENCY ROOM: AN UNRECOGNIZED SOURCE OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Plasmids; Thailand; Thienamycins; Young Adult | 2015 |
[The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cefuroxime; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli Infections; European Union; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Reference Standards; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli | 2015 |
Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blood; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Nursing Homes; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis; Retrospective Studies; Sputum; Taiwan; Thienamycins; Urine | 2016 |
[Characterization of class 1 and class 2 integron gene cassettes in Escherichia coli strains isolated from urine cultures: a multicenter study].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Escherichia coli Infections; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli | 2016 |
Antibiotic Sensitivity pattern of Bacterial Isolates of Neonatal Septicemia in Peshawar, Pakistan.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enoxacin; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant, Low Birth Weight; Infant, Newborn; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Neonatal Sepsis; Ofloxacin; Pakistan; Proteus; Proteus Infections; Pseudomonas; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis | 2016 |
Multi-drug resistant uropathogenic Escherichia coli and its treatment by Chinese medicine.
Topics: Animals; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drugs, Chinese Herbal; Escherichia coli Infections; Female; Imipenem; Mice, Inbred BALB C; Organ Specificity; Treatment Outcome; Uropathogenic Escherichia coli; Virulence | 2017 |
Isolation of Escherichia coli ST131 producing KPC-2 in Bulgaria.
Topics: Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Bulgaria; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cefotaxime; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Microbial Sensitivity Tests; Phylogeny; Plasmids | 2017 |
Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Critical Care; Doripenem; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Genotype; Humans; Imipenem; Klebsiella; Klebsiella Infections; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Thienamycins; United States | 2017 |
Atypical presentation of osteomyelitis, discitis, epidural, and iliopsoas abscess in diffuse idiopathic skeletal hyperostosis (DISH) syndrome.
Topics: Aged; Anti-Bacterial Agents; Discitis; Escherichia coli Infections; Humans; Hyperostosis, Diffuse Idiopathic Skeletal; Imipenem; Magnetic Resonance Imaging; Male; Osteomyelitis; Psoas Abscess; Radiography | 2008 |
Emergence of imipenem resistance in clinical Escherichia coli during therapy.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Genes, Bacterial; HIV Infections; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Mutation; Surgical Wound Infection; Virulence Factors | 2008 |
Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study.
Topics: Aged; Anti-Bacterial Agents; Ascites; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Retrospective Studies; Risk Factors; Treatment Failure | 2009 |
The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates from a general hospital in Iran.
Topics: Anti-Bacterial Agents; beta-Lactamases; Escherichia coli; Escherichia coli Infections; Female; Hospitals, General; Humans; Imipenem; Iran; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Prevalence | 2009 |
Characterization of multidrug resistant ESBL-producing Escherichia coli isolates from hospitals in Malaysia.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cluster Analysis; DNA Fingerprinting; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genotype; Humans; Imipenem; Integrases; Integrons; Malaysia; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Retrospective Studies | 2009 |
Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Spinal Diseases; Treatment Failure; Urinary Tract Infections | 2010 |
Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Citrobacter freundii; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Isoelectric Focusing; Meropenem; Microbial Sensitivity Tests; Middle Aged; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Thienamycins | 2011 |
Bacteriology of infection in severe acute pancreatitis.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Cephalosporins; Comorbidity; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Longitudinal Studies; Male; Middle Aged; Outcome Assessment, Health Care; Pancreatitis; Prevalence; Prospective Studies; Severity of Illness Index; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2011 |
Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Imipenem; Infant; Male; Middle Aged; Nitrofurantoin; Retrospective Studies; Tobramycin; Young Adult | 2011 |
[Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2011 |
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome | 2011 |
Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008-2009).
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Europe; Female; Humans; Imipenem; Intraabdominal Infections; Male; Microbial Sensitivity Tests | 2012 |
Transmission of imipenem resistance determinants during the course of an outbreak of NDM-1 Escherichia coli in a sick newborn care unit.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Disease Outbreaks; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Transfer, Horizontal; Humans; Imipenem; Infant, Newborn; Male; Molecular Sequence Data; Sepsis; Sequence Analysis, DNA | 2011 |
Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Cefoxitin; Ceftriaxone; Conjugation, Genetic; Disease Models, Animal; Drug Administration Schedule; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Kidney; Mice; Microbial Sensitivity Tests; Mutation Rate; Plasmids; Urinary Bladder; Urinary Tract Infections | 2012 |
Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility.
Topics: Adult; Bacteremia; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Thienamycins; Young Adult | 2012 |
A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Care; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Surgical Wound Infection | 2012 |
Occurrence and phenotypic detection of class A carbapenemases among Escherichia coli and Klebsiella pneumoniae blood isolates at a tertiary care center.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Prevalence; Sepsis; Tertiary Care Centers; Thienamycins | 2013 |
Determination of integron frequency by a polymerase chain reaction-restriction fragment length polymorphism method in multidrug-resistant Escherichia coli, which causes urinary tract infections.
Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Humans; Imipenem; Integrons; Male; Microbial Sensitivity Tests; Norfloxacin; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Urinary Tract Infections; Uropathogenic Escherichia coli | 2012 |
Efficacies of calcium-EDTA in combination with imipenem in a murine model of sepsis caused by Escherichia coli with NDM-1 β-lactamase.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactam Resistance; beta-Lactamases; Colony Count, Microbial; Disease Models, Animal; Edetic Acid; Escherichia coli; Escherichia coli Infections; Imipenem; Mice; Microbial Sensitivity Tests; Sepsis | 2013 |
Activity of combinations of ceftazidime, imipenem and pefloxacin against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa.
Topics: Animals; Ceftazidime; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Imipenem; In Vitro Techniques; Mice; Microbial Sensitivity Tests; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 2003 |
Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Bacteroides fragilis; Bacteroides Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; DNA, Bacterial; Drug Combinations; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Imipenem; Kidney; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Drug Synergism; Drug Therapy, Combination; Endotoxins; Escherichia coli; Escherichia coli Infections; Imipenem; Injections, Intraperitoneal; Insect Proteins; Lipopolysaccharides; Male; Piperacillin; Rats; Rats, Wistar; Shock, Septic | 2004 |
In vivo acquisition of high-level resistance to imipenem in Escherichia coli.
Topics: Anti-Bacterial Agents; Base Sequence; Child; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Microbial Sensitivity Tests | 2004 |
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cecum; Drug Therapy, Combination; Endotoxins; Escherichia coli; Escherichia coli Infections; Imipenem; Injections, Intraperitoneal; Limulus Test; Lipopolysaccharides; Male; Piperacillin; Polymyxin B; Rats; Rats, Wistar; Shock, Septic; Time Factors; Tumor Necrosis Factor-alpha | 2005 |
[Germs that produce the extended spectrum betalactamases].
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Emergencies; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Imipenem; Leukemia; Lymphoma, Non-Hodgkin; Male; Morocco; Neutropenia; Retrospective Studies; Shock, Septic; Time Factors | 2004 |
Escherichia coli: development of carbapenem resistance during therapy.
Topics: Aged; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins; Urinary Tract Infections | 2005 |
In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids; Selection, Genetic | 2005 |
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cathelicidins; Cecum; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Gram-Negative Bacteria; Imipenem; Injections, Intraperitoneal; Male; Nitrites; Piperacillin; Polymyxin B; Random Allocation; Rats; Rats, Wistar; Serotyping; Shock, Septic; Tumor Necrosis Factor-alpha | 2006 |
Isolation and characteristics of sorbitol-fermenting Escherichia coli O157 strains from cattle.
Topics: Adhesins, Bacterial; Animals; Anti-Bacterial Agents; Bacterial Toxins; Carbohydrate Epimerases; Cattle; Cattle Diseases; Cluster Analysis; DNA Fingerprinting; DNA, Bacterial; Escherichia coli Infections; Escherichia coli O157; Escherichia coli Proteins; Fermentation; Hemolysin Proteins; Hemolysis; Imipenem; Immunomagnetic Separation; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Serine Endopeptidases; Shiga Toxin 1; Shiga Toxin 2; Sorbitol; Transaminases; Virulence Factors | 2006 |
[Escherichia coli endocarditis: a report of two cases].
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Combined Modality Therapy; Endocarditis, Bacterial; Escherichia coli Infections; Female; Gastroenteritis; Gentamicins; Heart Valve Prosthesis Implantation; Humans; Imipenem; Middle Aged; Urinary Tract Infections | 2007 |
Ertapenem resistance of Escherichia coli.
Topics: Anti-Bacterial Agents; Antifungal Agents; beta-Lactams; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Fluconazole; Gentamicins; Humans; Imipenem; Immunocompromised Host; Middle Aged; Vancomycin | 2007 |
Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Military Personnel | 2007 |
Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Bile Duct Diseases; Community-Acquired Infections; Cross Infection; Drug Resistance; England; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Length of Stay; Male; Middle Aged; Odds Ratio; Prospective Studies; Urinary Tract Infections | 2007 |
Pharmacokinetics and bacteriological efficacy of N-formimidoyl thienamycin in experimental Escherichia coli meningitis.
Topics: Animals; Anti-Bacterial Agents; Escherichia coli Infections; Imipenem; Infusions, Parenteral; Injections, Intravenous; Kinetics; Lactams; Male; Meningitis; Rabbits | 1982 |
Therapeutic efficacy of a polymyxin B-dextran 70 conjugate in experimental model of endotoxemia.
Topics: Animals; Bacteremia; Dextrans; Disease Models, Animal; Drug Carriers; Endotoxins; Escherichia coli Infections; Female; Galactosamine; Imipenem; Lipopolysaccharides; Mice; Polymyxin B; Toxemia | 1995 |
Perforated acute appendicitis in a patient with AIDS/HIV infection: report of a case.
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Appendectomy; Appendicitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Escherichia coli Infections; Fever of Unknown Origin; Granulocyte Colony-Stimulating Factor; Humans; Imipenem; Immunization, Passive; Intestinal Perforation; Male; Postoperative Complications; Rupture, Spontaneous | 1995 |
Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of gram-negative sepsis.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Ceftazidime; Cell Wall; Escherichia coli Infections; Female; Galactosamine; Gram-Negative Bacterial Infections; Imipenem; Lipopolysaccharides; Mice; Mice, Inbred C3H; Sepsis | 1995 |
Psoas abscess following ileo-anal pouch surgery.
Topics: Adult; Colitis, Ulcerative; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Male; Proctocolectomy, Restorative; Psoas Abscess | 1995 |
Differential antibiotic-induced release of endotoxin from gram-negative bacteria.
Topics: Animals; Ceftazidime; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Female; Galactosamine; Imipenem; Lipid A; Lipopolysaccharides; Mice; Microbial Sensitivity Tests | 1994 |
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.
Topics: Abscess; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Body Weight; Disease Models, Animal; Drug Synergism; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gentamicins; Gram-Positive Bacterial Infections; Imipenem; Male; Microbial Sensitivity Tests; Ornidazole; Pefloxacin; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms | 1994 |
The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
Topics: Abscess; Animals; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Feces; Female; Imipenem; Immunocompromised Host; Liver; Metronidazole; Mice; Microbial Sensitivity Tests; Ofloxacin; Whole-Body Irradiation | 1994 |
Impact of different classes antimicrobial agents on plasma endotoxin activity.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Blood Pressure; Cefotaxime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Gentamicins; Imipenem; Male; Peritoneal Diseases; Peritoneum; Rats; Rats, Wistar; Thienamycins | 1996 |
[In vitro antibacterial activity of a new parenteral penem, sulopenem].
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Carrier Proteins; Cells, Cultured; Escherichia coli Infections; Hexosyltransferases; Imipenem; Lactams; Macrophages; Male; Mice; Mice, Inbred ICR; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases | 1996 |
[In vitro and in vivo activities of sulopenem compared with those of imipenem and cephalosporins].
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; Cefotaxime; Ceftizoxime; Cephalosporins; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Guinea Pigs; Imipenem; Klebsiella Infections; Lactams; Lung Diseases; Mice; Mice, Inbred ICR; Thienamycins | 1996 |
Bacteremia versus endotoxemia in experimental mouse leukopenia--role of antibiotic chemotherapy.
Topics: Animals; Antibodies, Monoclonal; Bacteremia; Ceftazidime; Cephalosporins; Cyclophosphamide; Endotoxemia; Escherichia coli; Escherichia coli Infections; Female; Galactosamine; Imipenem; Immunity, Innate; Interferon-gamma; Leukopenia; Mice; O Antigens; Thienamycins | 1996 |
Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.
Topics: Amino Acid Sequence; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Blotting, Southern; Carbapenems; Disease Outbreaks; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Infant; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids | 1997 |
[A case of septic shock following incarceration of the penis].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Escherichia coli Infections; gamma-Globulins; Humans; Imipenem; Male; Methylprednisolone; Minocycline; Penis; Shock, Septic | 1998 |
[Clinical of 50 cases of aged patients with pneumonia caused by gram-negative bacteria].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Kanamycin; Male; Middle Aged; Penicillins; Pneumonia, Bacterial; Thienamycins | 1998 |
[A case of effective endotoxin adsorption therapy for septic shock due to acute pyelonephritis].
Topics: Acute Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Endotoxins; Escherichia coli; Escherichia coli Infections; Hemofiltration; Humans; Imipenem; Male; Middle Aged; Pyelonephritis; Shock, Septic; Sorption Detoxification; Treatment Outcome; Ureteral Calculi | 2000 |
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Disease Models, Animal; Endotoxemia; Escherichia coli Infections; Imipenem; Male; Peptides, Cyclic; Polymyxin B; Polymyxins; Rats; Survival Rate; Thienamycins; Tumor Necrosis Factor-alpha | 2001 |
Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.
Topics: Adult; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Blotting, Western; Cephalosporin Resistance; Conjugation, Genetic; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Gene Amplification; Humans; Imipenem; Male; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA | 2002 |
Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Escherichia coli Infections; Imipenem; Male; Mice; Nitric Oxide Synthase; omega-N-Methylarginine; Peritonitis | 1992 |
Bilateral emphysematous pyelonephritis resolving to medical therapy.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Emphysema; Escherichia coli Infections; Female; Humans; Imipenem; Middle Aged; Pyelonephritis; Tomography, X-Ray Computed | 1992 |
Relation between the therapeutic efficacy of imipenem in an experimental infection in granulocytopenic mice and its effect on murine intestinal microbial ecology.
Topics: Animals; Cilastatin; Cilastatin, Imipenem Drug Combination; Colony Count, Microbial; Drug Combinations; Escherichia coli Infections; Imipenem; Injections, Subcutaneous; Intestines; Male; Mice; Muscular Diseases; Specific Pathogen-Free Organisms; Thigh | 1990 |
Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections.
Topics: Abscess; Animals; Bacterial Infections; Cefotaxime; Cefpirome; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Granuloma; Imipenem; Male; Mice; Mice, Hairless; Mice, Inbred C3H; Pneumonia; Rats; Rats, Inbred Strains; Sepsis; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections | 1990 |
Evaluation of FCE 22101 in experimental meningitis caused by Escherichia coli and Streptococcus pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Blood Bactericidal Activity; Carbapenems; Ceftriaxone; Escherichia coli Infections; Imipenem; Meningitis; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillins; Rabbits | 1989 |
[Clinical and pharmacokinetic study of imipenem/cilastatin in children and newborn infants].
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Imipenem; Infant, Newborn; Male; Pseudomonas Infections; Serratia | 1989 |
In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
Topics: Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefamandole; Cefotetan; Cefoxitin; Ceftizoxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Imipenem; Male; Mice; Skin Diseases; Sulbactam | 1989 |
Therapeutic effects of imipenem-cilastatin on experimental intrauterine infections in rats.
Topics: Ampicillin; Animals; Cefazolin; Cilastatin; Cyclopropanes; Drug Combinations; Drug Evaluation, Preclinical; Endometritis; Enterococcus faecalis; Escherichia coli Infections; Female; Imipenem; Microbial Sensitivity Tests; Neutropenia; Rats; Rats, Inbred Strains; Streptococcal Infections; Thienamycins | 1987 |
[A clinical study on imipenem/cilastatin sodium in the field of pediatrics].
Topics: Bacterial Infections; Child, Preschool; Cilastatin; Cyclopropanes; Drug Combinations; Escherichia coli Infections; Female; Gastroenteritis; Haemophilus Infections; Humans; Imipenem; Infant; Male; Neisseria; Respiratory Tract Infections; Streptococcal Infections; Thienamycins; Urinary Tract Infections | 1986 |
Imipenem/cilastatin for the treatment of infections in hospitalized children.
Topics: Arthritis, Infectious; Bacterial Infections; Cellulitis; Child; Child, Preschool; Cilastatin; Cyclopropanes; Dipeptidases; Drug Combinations; Escherichia coli Infections; Female; Haemophilus Infections; Hospitalization; Humans; Imipenem; Infant; Kidney Diseases; Lymphadenitis; Male; Prospective Studies; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections; Thienamycins; Wound Infection | 1985 |
Comparison of cefotaxime, imipenem-cilastatin, ampicillin-gentamicin, and ampicillin-chloramphenicol in the treatment of experimental Escherichia coli bacteremia and meningitis.
Topics: Ampicillin; Animals; Animals, Newborn; Cefotaxime; Chloramphenicol; Cilastatin; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Imipenem; Meningitis; Rats; Sepsis; Thienamycins | 1985 |